Dr. Anil Mandhani - Urology

Dr. Anil

Dr. Anil Mandhani - Urology

  • 29 Years of experience
  • Registration No: Medanta 3
  • Gender: Male
  • Associated With: Medanta - The Medicity
  • CH Baktawar Singh Road, Sector 38
  • (+91) 9810434377, (+91) 9560398936, (+91) 9650898570
  • ips2@medanta.org
  • Languages spoken: English, Hindi
  • Practicing since: 1990
  • Contact Doctor

About the Doctor

Dr. Anil Mandhani is the Chairman of Kidney and Urology Institute at Medanta – The Medicity. He is a renowned urologist who has conducted a variety of complex oncological and reconstructive surgeries for various cancers including prostate, testicular and penile. Having worked in Sanjay Gandhi Post Graduate Institute of Medical Sciences for 20 years as Professor, Urology, Dr. Mandhani has vast experience in clinical and basic science research in managing various cancers in urology. He has also been a clinical fellow in Robotic uro-oncology at Institute of Robotic Surgery, Cornell/ New York Presbyterian Hospital, New York. Before joining Medanta, Dr. Mandhani worked at Fortis Escorts Hospital, New Delhi as Director, Kidney and Urology Institute.

 

  • Degree and residency
  • Professional Experience
  • Achievements
  • Research
Degree and residency
Degree: Pt JNM Medical College, Ravishankar University, Raipur
Residency: Cornell/ New York Presbyterian Hospital, New York
Professional Experience

More than two decades of experience in Urology. Former Professor, Urology at Sanjay Gandhi Post Graduate Institute of Medical Sciences. Clinical Fellow in robotic uro-oncology at Cornell Presbyterian Hospital, New York

Achievements

• DUSUCON North zone urological society of India for best research work award, 2014

• DUSUCON award on best clinical work on PSA characteristic in prostate cancer, 2013

Research

• ICMR : To study the impact of chronic asymptomatic prostatitis on serum PSA level measuring seminal fluid interleukin-8 levels and its gene polymorphism

• UPCST : Expression of androgen receptors at various stages of metastatic prostatic cancer and correlation with response pattern to ADT

• Cancer research grant from Pfizer : Correlation of natural killer cell counts in whole blood and human leukocyte and antigen-g expression in tumor tissue of renal cell carcinoma patients.

• Cancer research grant from Pfizer : Finding targets of micro RNA by western blot techniques in bladder cancer

• Cancer research grant from Pfizer : Assessment of micro RNA expression and validation of its utility as a new marker of prognosticating the outcome of bladder cancer

• Cancer research grant from Pfizer : Prediction of stone fragility by dual energy x-ray absorptiometry, • Cancer research grant from Pfizer : Renal cell carcinoma in India present at an early age and in advanced stage,

• Toxicol Int : Tobacco exposure may enhance inflammation in prostate carcinoma patients: an explorative study in North Indian population., 2012

• Indian J Urol. : Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines?, 2012

• Indian J Urol. : Does en-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen?, 2012

  • Specialities & Procedures
  • Memberships Associations
  • Healthcare provider
Specialities & Procedures

Transplant      Learn more

  • Renal Transplant

Urology      Learn more

  • Cancer
  • Endo-Urological Surgery
  • Robotic Surgery
  • Urology Consultation
Memberships Associations

• Corresponding member of AUA

• Member of European Urology

• Fellow of American College of Surgeons

• Member of BAUS

• Member of Urological Society of India

Healthcare provider